BiotechTube

Prednisone + Vinblastine + Doxorubicin (Adriamycin) + Gemcitabine

Phase 1/2Completed
0 watching 0 views this week⚡ Active
41
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Hodgkin's Disease

Conditions

Hodgkin's Disease

Trial Timeline

Mar 1, 2004 → —

NCT ID
NCT00147875

About Prednisone + Vinblastine + Doxorubicin (Adriamycin) + Gemcitabine

Prednisone + Vinblastine + Doxorubicin (Adriamycin) + Gemcitabine is a phase 1/2 stage product being developed by Eli Lilly for Hodgkin's Disease. The current trial status is completed. This product is registered under clinical trial identifier NCT00147875. Target conditions include Hodgkin's Disease.

Hype Score Breakdown

Clinical
13
Activity
8
Company
10
Novelty
4
Community
3

Clinical Trials (1)

NCT IDPhaseStatus
NCT00147875Phase 1/2Completed

Competing Products

20 competing products in Hodgkin's Disease

See all competitors
ProductCompanyStageHype Score
YM155 + RituximabAstellas PharmaPhase 2
52
TazemetostatEisaiPhase 2
52
ONTAKEisaiPhase 2
52
TazemetostatEisaiPhase 1
33
ME-401Kyowa KirinPhase 1
33
ME-401Kyowa KirinPhase 2
52
Nivolumab + Brentuximab vedotinOno PharmaceuticalPhase 3
77
R-mabHDI and ABVD + ABVDEli LillyPhase 3
77
gemcitabineEli LillyPhase 2
52
gemcitabine + cisplatin + dexamethasoneEli LillyPhase 2
52
R-mabHD + ABVDEli LillyPhase 2
52
LY317615Eli LillyPhase 2
52
LY4584180 + RituximabEli LillyPhase 1
33
Bortezomib + Rituximab + RituximabJohnson & JohnsonPhase 3
77
HRS-3738Jiangsu Hengrui MedicinePhase 1
33
SHR1459 ；YY-20394 + SHR1459 ；YY-20394 + Gemcitabine-OxaliplatinJiangsu Hengrui MedicinePhase 2
52
ABT-199 + KetoconazoleAbbViePhase 1
33
ABT-199 + RifampinAbbViePhase 1
33
[14C]ABT-199 (GDC-0199)AbbViePhase 1
33
ABT-199 + Rituximab + BendamustineAbbViePhase 1
33

Other Products from Eli Lilly

Insulin Glargine + Insulin Lispro Premix (mid-mixture and low-mixture)Approved
85
Olanzapine + PlaceboApproved
85
exenatide and sitagliptin + exenatide and placeboApproved
85
Tirzepatide + PlaceboApproved
85
tadalafilApproved
85